AMR SVG Icons location

News / American Regent

American Regent Announces the Launch and Availability of Fomepizole Injection, AP Rated and Therapeutically Equivalent to Antizol®

28 Aug 2018

Shirley, NY — American Regent today announced the launch and availability of Fomepizole Injection, AP rated and therapeutically equivalent to Antizol®.

Read more

St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship

The program offers fellowships in both Medical Affairs & Pharmaceutical Marketing and in Clinical Research & Development.

Read more

American Regent Announces the FDA Approval of Hydroxyprogesterone Caproate Injection, USP; the First Preservative Free, AP Rated Generic to Makena®

25 Jun 2018

Shirley, NY — American Regent today announced the launch of Hydroxyprogesterone Caproate Injection, USP, the only preservative free generic alternative to Makena®.

Read more

American Regent Announces the Availability of Neostigmine Methylsulfate Injection, USP; AP Rated and Therapeutically Equivalent to Bloxiverz®

Shirley, NY — American Regent today announced the introduction of Neostigmine Methylsulfate Injection, USP. Product is available for immediate shipment and customers can order through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of FDA Approved 10% Calcium Chloride Injection, USP

16 Feb 2018

Shirley, NY — American Regent today announced the launch of 10% Calcium Chloride Injection, USP. 10% Calcium Chloride Injection, USP is available for immediate shipment. Customers can order 10% Calcium Chloride Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of Methocarbamol Injection, USP; AP Rated and Therapeutically Equivalent to Robaxin®

30 Jan 2018

Shirley, NY — American Regent today announced the launch of Methocarbamol Injection, USP. Methocarbamol Injection, USP is available for immediate shipment. Customers can order Methocarbamol Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of Dicyclomine Hydrochloride Injection, USP; AP Rated and Therapeutically Equivalent to Bentyl®

1 Sep 2017

Shirley, NY — American Regent today announced the introduction of Dicyclomine Hydrochloride Injection, USP. Dicyclomine Hydrochloride Injection, USP is available for immediate shipment. Customers can order Dicyclomine Hydrochloride Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of Hydroxyzine HCl Injection, USP; AP Rated and therapeutically equivalent to Vistaril®

15 May 2017

Shirley, NY — American Regent today announced the reintroduction of Hydroxyzine HCl Injection, USP. Hydroxyzine HCl Injection, USP is available for immediate shipment. Customers can order Hydroxyzine HCl Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces Enrollment of First Patient in Phase 3 Trial to Investigate Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency

24 Apr 2017

Shirley, NY — American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. This double-blind, multicenter, prospective, randomized, placebo-controlled study will assess the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of patients with heart failure, iron deficiency and a reduced ejection fraction.

Read more

American Regent announces the commercial availability of Busulfan Injection, the First and Only AP Rated Therapeutically Equivalent Generic to Busulfex®

1 Mar 2017

Shirley, NY — American Regent today announced the launch of Busulfan Injection, which had been previously approved by the U.S. Food and Drug Administration.

Read more